Ticlopidine hydrochloride is an antiplatelet drug used to prevent strokes and blood clots. It is prescribed after coronary stent placement to reduce the risk of thrombosis. Also used in patients with peripheral arterial disease or aspirin intolerance. Regular blood monitoring is required due to risk of serious blood disorders. It is grouped under the following drug class(es): Antiplatelets and Antithrombotic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Ticlid, Panaldine, Ticlodix, Tiklid and Ipaton. Its PubChem CID is 65335.
Ticlopidine hydrochloride
| CAS No | 53885-35-1 |
|---|---|
| Molecular Formula | C14H15Cl2NS |
| Molecular Weight | 300.2 g/mol |
| Synonyms | 5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ticlopidine hydrochloride is an antiplatelet drug used to prevent strokes and blood clots. It is prescribed after coronary stent placement to reduce the risk of thrombosis.
The listed CAS number is 53885-35-1.
The listed molecular formula is C14H15Cl2NS.
The listed molecular weight is 300.2 g/mol.
5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine;hydrochloride.
The source lists Ticlid, Panaldine, Ticlodix, Tiklid and Ipaton.